Cerebain Biotech Announces Next Major Step In Its Fight Against Alzheimers

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DALLAS--(BUSINESS WIRE)--Cerebain Biotech Corp. (“Cerebain” or “the Company”), a subsidiary of Discount Dental Materials, Inc. (OTCBB: DDOO), announced that medical device product development company, Sonos Models, Inc. (“Sonos”), is set to procure pig omentum for the purpose of testing the first Prototypes of our medical device product for treatment of Alzheimer’s. \

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC